Canada reports 15 cases of Omicron variant, says severe Covid trends could rise | Inquirer News

Canada reports 15 cases of Omicron variant, says severe Covid trends could rise

/ 10:59 AM December 04, 2021

Canada Omicron Covid-19

Women walk through Toronto’s PATH, the world’s biggest underground shopping mall that runs under the city’s major downtown office buildings, in Toronto, Ontario, Canada September 28, 2021. (Reuters) 

OTTAWA–Canada has discovered a total of 15 cases of the new Omicron variant of Covid-19 and severe illness trends across the country could start to rise again, public health officials said on Friday.

The federal government said it backed a recommendation of a national advisory board on immunizations that all adults above 50 should receive a booster shot six months after completion of a vaccine series.

ADVERTISEMENT

Ottawa announced last week it will require people arriving by air from all nations except the United States to take a Covid-19 test, and it expanded a ban on travelers from southern Africa to cover 10 nations.

FEATURED STORIES

“The need for heightened vigilance remains, regardless of which variant is circulating,” chief public health officer Theresa Tam told reporters. She announced 11 Omicron cases, all involving people who had recently traveled abroad.

Hours after she spoke, the city of York said a child under 12 had been diagnosed with Omicron. The child had recently traveled to southern Africa, it said in a statement.

Toronto then reported its first three cases of the Omicron Covid-19 variant late on Friday, local health officials said, with two of those individuals having recently returned from Nigeria, while another individual had returned from Switzerland.

“Currently severe illness trends have leveled off, but are still elevated and could begin to rise again, unless we keep infection rates down,” Tam said.

Procurement Minister Anita Anand said Canada had signed a deal with Pfizer inc for a million doses of its oral antiviral medicine for the treatment of Covid-19, and a deal with Merck & Co for a 500,000 doses of a similar pill.

The deals depend on approval from federal regulators. Merck said Ottawa had secured access to 500,000 courses in 2022, with options for up to 500,000 more.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Canada, COVID-19, Omicron

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.